Vivos Therapeutics (VVOS) Short Interest Ratio & Short Volume $3.20 -0.29 (-8.31%) Closing price 03/26/2025 04:00 PM EasternExtended Trading$3.39 +0.19 (+5.94%) As of 03/26/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vivos Therapeutics Short Interest DataVivos Therapeutics (VVOS) has a short interest of 249,000 shares, representing 5.42% of the float (the number of shares available for trading by the public). This marks a -27.62% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 475,266 shares to cover all short positions.Current Short Interest249,000 sharesPrevious Short Interest344,000 sharesChange Vs. Previous Month-27.62%Dollar Volume Sold Short$821,700.00Short Interest Ratio1.2 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares5,890,000 sharesFloat Size4,590,000 sharesShort Percent of Float5.42%Today's Trading Volume76,771 sharesAverage Trading Volume475,266 sharesToday's Volume Vs. Average16% Short Selling Vivos Therapeutics? Sign up to receive the latest short interest report for Vivos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVVOS Short Interest Over TimeVVOS Days to Cover Over TimeVVOS Percentage of Float Shorted Over Time Remove Ads Vivos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025249,000 shares $821,700.00 -27.6%5.4%1.2 $3.30 2/28/2025344,000 shares $1.19 million +22.1%7.5%1.5 $3.47 2/15/2025281,700 shares $1.13 million +0.1%6.1%1.1 $4.00 1/31/2025281,400 shares $1.12 million +3.1%6.1%1.1 $3.97 1/15/2025273,000 shares $1.40 million +134.9%6.3%1.1 $5.12 12/31/2024116,200 shares $498,498.00 -21.5%2.7%0.6 $4.29 12/15/2024148,000 shares $682,280.00 +28.9%3.9%0.7 $4.61 11/30/2024114,800 shares $391,468.00 -12.2%2.7%0.1 $3.41 11/15/2024130,800 shares $371,472.00 +37.5%3.0%0.1 $2.84 10/31/202495,100 shares $239,652.00 +36.3%2.2%0.1 $2.52 Get the Latest News and Ratings for VVOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202469,800 shares $172,406.00 -25.4%1.6%0.1 $2.47 9/30/202493,600 shares $244,296.00 +46.9%2.3%0.1 $2.61 9/15/202463,700 shares $187,915.00 +12.0%2.0%0 $2.95 8/31/202456,900 shares $154,199.00 -34.9%1.8%0.9 $2.71 8/15/202487,400 shares $194,902.00 +54.7%2.7%1.4 $2.23 7/31/202456,500 shares $129,950.00 -3.9%1.8%0.9 $2.30 7/15/202458,800 shares $164,052.00 -40.1%1.8%0.9 $2.79 6/30/202498,100 shares $217,782.00 +92.0%3.1%0.7 $2.22 6/15/202451,100 shares $114,975.00 +5.6%1.6%0.3 $2.25 5/31/202448,400 shares $101,156.00 +4.3%1.6%0.3 $2.09 5/15/202446,400 shares $101,152.00 -26.1%1.6%0.3 $2.18 4/30/202462,800 shares $158,884.00 -67.1%2.3%0.3 $2.53 4/15/2024191,100 shares $529,347.00 +921.9%7.6%0.9 $2.77 3/31/202418,700 shares $90,321.00 -28.6%0.8%0.1 $4.83 3/15/202426,200 shares $117,900.00 +11.0%2.3%0.2 $4.50 2/29/202423,600 shares $137,116.00 -19.2%2.1%0.1 $5.81 2/15/202429,200 shares $156,512.00 -38.1%2.6%0 $5.36 1/31/202447,200 shares $347,864.00 +237.1%4.2%0 $7.37 1/15/202414,000 shares $111,300.00 -84.0%1.2%0 $7.95 12/31/202387,300 shares $1.09 million -46.2%N/A0 $12.44 12/15/2023162,300 shares $1.49 million +512.5%14.6%0.1 $9.21 11/30/202326,500 shares $649,250.00 -31.2%2.4%0 $24.50 11/15/202338,500 shares $148,225.00 +13.2%3.9%0.2 $3.85 10/31/202334,000 shares $109,140.00 -98.5%3.4%0.2 $3.21 10/15/20232,270,000 shares $732,302.00 +297.1%N/A0.4 $0.32 9/30/2023571,600 shares $109,804.36 +8.3%N/A0.1 $0.19 9/15/2023527,700 shares $129,286.50 -18.9%N/A0.3 $0.25 8/31/2023650,300 shares $163,420.39 -43.0%N/A0.4 $0.25 8/15/20231,140,000 shares $372,096.00 +1,388.3%N/A0.7 $0.33 7/31/202376,600 shares $22,290.60 -33.6%N/A0.1 $0.29Alert: DOGE goes live (Ad)Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.Click here to learn more. 7/15/2023115,300 shares $36,492.45 +63.3%N/A0.5 $0.32 6/30/202370,600 shares $36,006.00 -69.7%N/A0.5 $0.51 6/15/2023232,900 shares $128,421.06 -5.2%N/A1.4 $0.55 5/31/2023245,600 shares $93,720.96 +11.5%N/A1.3 $0.38 5/15/2023220,200 shares $72,666.00 +48.1%N/A0.3 $0.33 4/30/2023148,700 shares $51,152.80 -21.9%N/A0.2 $0.34 4/15/2023190,400 shares $63,574.56 +31.7%N/A0.3 $0.33 3/31/2023144,600 shares $49,323.06 -45.1%N/A0.2 $0.34 3/15/2023263,500 shares $96,599.10 +449.0%1.3%0.1 $0.37 2/28/202348,000 shares $29,280.00 -82.9%0.2%0 $0.61 2/15/2023281,000 shares $256,384.40 -5.9%1.4%0.1 $0.91 1/31/2023298,700 shares $325,583.00 -65.5%1.7%0.1 $1.09 1/15/2023865,100 shares $1.51 million +576.4%4.8%0.4 $1.75 12/30/2022127,900 shares $51,415.80 +10.6%0.7%0.1 $0.40 12/15/2022115,600 shares $40,286.60 -16.4%0.6%1.6 $0.35 11/30/2022138,200 shares $69,100.00 -17.8%0.8%3.5 $0.50 11/15/2022168,200 shares $115,368.38 -22.8%0.9%4.9 $0.69 10/31/2022217,900 shares $156,888.00 +29.0%1.2%5.2 $0.72 10/15/2022168,900 shares $116,000.52 -0.2%0.9%4 $0.69 9/30/2022169,300 shares $110,028.07 +19.1%0.9%4.2 $0.65 9/15/2022142,100 shares $161,994.00 -20.9%0.8%3.8 $1.14 8/31/2022179,600 shares $220,908.00 +26.5%1.0%4.3 $1.23 8/15/2022142,000 shares $200,220.00 -43.6%0.8%3 $1.41 7/31/2022251,600 shares $289,340.00 +19.9%1.4%5.3 $1.15 7/15/2022209,800 shares $295,818.00 -17.4%1.2%3.9 $1.41 6/30/2022254,100 shares $327,789.00 -3.6%1.5%4.3 $1.29 6/15/2022263,500 shares $337,280.00 -32.5%1.5%3.5 $1.28 5/31/2022390,500 shares $792,715.00 -4.9%2.3%4.9 $2.03 5/15/2022410,700 shares $570,873.00 +50.6%2.4%3.5 $1.39 4/30/2022272,800 shares $471,944.00 -32.2%1.6%1.9 $1.73 4/15/2022402,300 shares $788,508.00 -16.8%2.3%0.8 $1.96 3/31/2022483,600 shares $1.30 million -5.7%2.8%0.2 $2.68 3/15/2022512,900 shares $1.38 million -31.4%3.0%0.2 $2.69 2/28/2022747,700 shares $2.50 million +54.3%4.3%0.4 $3.34 2/15/2022484,700 shares $1.17 million -60.6%2.8%0.2 $2.42 1/31/20221,230,000 shares $3.04 million +760.1%7.1%0.6 $2.47 1/15/2022143,000 shares $267,410.00 -10.8%1.0%0.1 $1.87 12/31/2021160,300 shares $360,675.00 -15.8%1.2%1.2 $2.25 12/15/2021190,400 shares $531,216.00 -36.6%1.4%1.3 $2.79 11/30/2021300,300 shares $765,765.00 -19.0%2.2%1.4 $2.55 11/15/2021370,800 shares $1.51 million -11.6%2.7%1.1 $4.06 10/29/2021419,400 shares $1.52 million +41.6%3.1%0.1 $3.63 10/15/2021296,200 shares $1.05 million +3.6%2.2%0.1 $3.55 9/30/2021285,800 shares $1.15 million -0.1%2.1%0.1 $4.04 9/15/2021286,200 shares $1.35 million -56.2%2.1%0.1 $4.73 8/31/2021652,700 shares $3.43 million +1,390.2%4.8%0.2 $5.26 8/13/202143,800 shares $143,226.00 -25.8%0.3%0 $3.27 7/30/202159,000 shares $178,180.00 -50.7%0.4%0.2 $3.02 7/15/2021119,700 shares $514,710.00 +193.4%0.9%0.4 $4.30 6/30/202140,800 shares $201,960.00 -17.7%0.3%0.1 $4.95Alert: DOGE goes live (Ad)Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.Click here to learn more. 6/15/202149,600 shares $288,176.00 -22.0%0.4%0.3 $5.81 5/28/202163,600 shares $342,168.00 +1.0%0.5%0.3 $5.38 5/14/202163,000 shares $372,960.00 +90.3%0.5%0.4 $5.92 4/30/202133,100 shares $223,425.00 -45.7%0.3%0.2 $6.75 4/15/202160,900 shares $542,010.00 +45.4%0.6%0.3 $8.90 3/31/202141,900 shares $283,663.00 +165.2%0.4%0.2 $6.77 3/15/202115,800 shares $117,552.00 -31.9%0.2%0.1 $7.44 2/26/202123,200 shares $174,928.00 -33.9%0.2%0 $7.54 2/12/202135,100 shares $245,349.00 +317.9%0.3%0.1 $6.99 1/29/20218,400 shares $56,658.00 -88.0%0.1%0 $6.75 1/15/202170,100 shares $560,099.00 No Change0.6%0.1 $7.99 VVOS Short Interest - Frequently Asked Questions What is Vivos Therapeutics' current short interest? Short interest is the volume of Vivos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 344,000 shares of VVOS short. 7.49% of Vivos Therapeutics' shares are currently sold short. Learn More on Vivos Therapeutics' current short interest. What is a good short interest ratio for Vivos Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VVOS shares currently have a short interest ratio of 2.0. Learn More on Vivos Therapeutics's short interest ratio. Which institutional investors are shorting Vivos Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vivos Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vivos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.49% of Vivos Therapeutics' floating shares are currently sold short. Is Vivos Therapeutics' short interest increasing or decreasing? Vivos Therapeutics saw a increase in short interest in February. As of February 28th, there was short interest totaling 344,000 shares, an increase of 22.1% from the previous total of 281,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vivos Therapeutics' float size? Vivos Therapeutics currently has issued a total of 5,890,000 shares. Some of Vivos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vivos Therapeutics currently has a public float of 4,590,000 shares. How does Vivos Therapeutics' short interest compare to its competitors? 7.49% of Vivos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Vivos Therapeutics: Sensus Healthcare, Inc. (6.24%), Nutriband Inc. (5.50%), Vivani Medical, Inc. (0.95%), Fractyl Health, Inc. (14.50%), iCAD, Inc. (0.92%), Cytosorbents Co. (3.62%), Microbot Medical Inc. (19.58%), Inovio Pharmaceuticals, Inc. (15.40%), electroCore, Inc. (2.29%), Apyx Medical Co. (0.43%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short Vivos Therapeutics stock? Short selling VVOS is an investing strategy that aims to generate trading profit from Vivos Therapeutics as its price is falling. VVOS shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vivos Therapeutics? A short squeeze for Vivos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VVOS, which in turn drives the price of the stock up even further. How often is Vivos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVOS, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies SRTS Short Interest NTRB Short Interest VANI Short Interest GUTS Short Interest ICAD Short Interest CTSO Short Interest MBOT Short Interest INO Short Interest ECOR Short Interest APYX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VVOS) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
